Older Women With High-Risk Breast Cancer Addition of Adjuvant Chemotherapy to Hormone Therapy - T...

Older Women With High-Risk Breast Cancer Addition of Adjuvant Chemotherapy to Hormone Therapy  The ASCO Post

Kefah Mokbel: Five or Ten Years of Adjuvant Endocrine Therapy for Breast Cancer? - Oncodaily

Kefah Mokbel: Five or Ten Years of Adjuvant Endocrine Therapy for Breast Cancer?  Oncodaily

Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer - The New England...

Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer  The New England Journal of Medicine

Efficacy of dexmedetomidine as an adjuvant to ropivacaine for intercos | JPR - Dove Medical Press

Efficacy of dexmedetomidine as an adjuvant to ropivacaine for intercos | JPR  Dove Medical Press

An Il12 mRNA-LNP adjuvant enhances mRNA vaccine–induced CD8 T cell responses - Science | AAAS

An Il12 mRNA-LNP adjuvant enhances mRNA vaccine–induced CD8 T cell responses  Science | AAAS

Elicio Therapeutics Announces Publication of ELI-002 Updated AMPLIFY-201 Phase 1 Follow-up Data i...

Elicio Therapeutics Announces Publication of ELI-002 Updated AMPLIFY-201 Phase 1 Follow-up Data in Nature Medicine for Minimal Residual Disease (“MRD”) Positive, Adjuvant-Stage Patients  Stock Titan

Molecular residual disease analysis of adjuvant osimertinib in resected EGFR -mutated stage IB–II...

Molecular residual disease analysis of adjuvant osimertinib in resected EGFR -mutated stage IB–IIIA non-small-cell lung cancer  nature.com

Lipid nanoparticles with prazole adjuvant to enhance the efficacy of mRNA cancer vaccines - Scien...

Lipid nanoparticles with prazole adjuvant to enhance the efficacy of mRNA cancer vaccines  ScienceDirect.com

Vaccine-Enhancing Adjuvant Library Launches - Vax-Before-Travel

Vaccine-Enhancing Adjuvant Library Launches  Vax-Before-Travel

ASCO GU 2025: Discussant: Adjuvant Immunotherapy in High Risk Muscle Invasive Bladder Cancer - Ur...

ASCO GU 2025: Discussant: Adjuvant Immunotherapy in High Risk Muscle Invasive Bladder Cancer  UroToday

Adjuvant Immunotherapy in High-Risk Cutaneous Squamous Cell Carcinoma - Cleveland Clinic

Adjuvant Immunotherapy in High-Risk Cutaneous Squamous Cell Carcinoma  Cleveland Clinic

Adjuvant Therapy for Breast Cancer: Practice Essentials, Overview, Combination Regimens for Breas...

Adjuvant Therapy for Breast Cancer: Practice Essentials, Overview, Combination Regimens for Breast Cancer  Medscape

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer - The New England Journal of Med...

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer  The New England Journal of Medicine

Linking vaccine adjuvant mechanisms of action to function - Science | AAAS

Linking vaccine adjuvant mechanisms of action to function  Science | AAAS

A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae ...

A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae induces protective immune responses in a murine model  nature.com

Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell Carcinoma - The ASCO Post

Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell Carcinoma  The ASCO Post

Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma - The New England J...

Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma  The New England Journal of Medicine

Calboxyvinyl polymer adjuvant enhances respiratory IgA responses through mucosal and systemic adm...

Calboxyvinyl polymer adjuvant enhances respiratory IgA responses through mucosal and systemic administration  nature.com

ASCO 2025: Adding Atezolizumab to Adjuvant Chemotherapy Improves Disease-Free Survival in dMMR Co...

ASCO 2025: Adding Atezolizumab to Adjuvant Chemotherapy Improves Disease-Free Survival in dMMR Colon Cancer  The ASCO Post

Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes...

Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial  nature.com

Adjuvant Systemic Therapies for Urothelial Carcinoma: Current Evidence and Future Directions - Je...

Adjuvant Systemic Therapies for Urothelial Carcinoma: Current Evidence and Future Directions - Jean Hoffman-Censits  UroToday

Adjuvant Osimertinib in EGFR-Mutated NSCLC: The Survival Curves Reveal the Next Set of Questions ...

Adjuvant Osimertinib in EGFR-Mutated NSCLC: The Survival Curves Reveal the Next Set of Questions on How to Optimize Benefits  ASCO Daily News

Saponin-based adjuvant uptake and induction of antigen cross-presentation by CD11b+ dendritic cel...

Saponin-based adjuvant uptake and induction of antigen cross-presentation by CD11b+ dendritic cells and macrophages  nature.com

ASCO GU 2025: Adjuvant Therapy in Renal Cell Cancer: A Practical Guide - UroToday

ASCO GU 2025: Adjuvant Therapy in Renal Cell Cancer: A Practical Guide  UroToday

Multimodal data integration for biologically-relevant artificial intelligence to guide adjuvant c...

Multimodal data integration for biologically-relevant artificial intelligence to guide adjuvant chemotherapy in stage II colorectal cancer  The Lancet

SUO 2024: Adjuvant Systemic Therapy in Urothelial Carcinoma: Where Are We At Today? - UroToday

SUO 2024: Adjuvant Systemic Therapy in Urothelial Carcinoma: Where Are We At Today?  UroToday

C-POST: Adjuvant Cemiplimab Reduces Risk of Recurrence in Patients With High-Risk Cutaneous Squam...

C-POST: Adjuvant Cemiplimab Reduces Risk of Recurrence in Patients With High-Risk Cutaneous Squamous Cell Carcinoma  ASCO Daily News

Reductive Adjuvant Nanosystem for Alleviated Atopic Dermatitis Syndromes - ACS Publications

Reductive Adjuvant Nanosystem for Alleviated Atopic Dermatitis Syndromes  ACS Publications

Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis ...

Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate  nature.com

Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Tu...

Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study  nature.com

Dual-Functional Antibiotic Adjuvant Displays Potency against Complicated Gram-Negative Bacterial ...

Dual-Functional Antibiotic Adjuvant Displays Potency against Complicated Gram-Negative Bacterial Infections and Exhibits Immunomodulatory Properties  ACS Publications

Prognostic value of adjuvant chemotherapy for hormone receptor-negative T1a and T1bN0M0 breast ca...

Prognostic value of adjuvant chemotherapy for hormone receptor-negative T1a and T1bN0M0 breast cancer patients  nature.com

Adjuvant Nivolumab Plus Chemoradiotherapy Meets DFS End Point in Locally Advanced HNSCC - OncLive

Adjuvant Nivolumab Plus Chemoradiotherapy Meets DFS End Point in Locally Advanced HNSCC  OncLive

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma - The New Engla...

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma  The New England Journal of Medicine

Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an internat...

Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial  The Lancet

Vaccine Developers To Benefit From CEPI’s ‘World First’ Adjuvant ‘Matchmaking’ Service - insights...

Vaccine Developers To Benefit From CEPI’s ‘World First’ Adjuvant ‘Matchmaking’ Service  insights.citeline.com

Adjuvant Cemiplimab Improves DFS in High-Risk Cutaneous Squamous Cell Carcinoma - OncLive

Adjuvant Cemiplimab Improves DFS in High-Risk Cutaneous Squamous Cell Carcinoma  OncLive

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with cap...

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a rando  The Lancet

Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a ...

Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials  The Lancet

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized ...

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2– breast cancer (LEADER) | npj Breast Cancer  nature.com

Spleen-Targeted mRNA Vaccine Doped with Manganese Adjuvant for Robust Anticancer Immunity In Vivo...

Spleen-Targeted mRNA Vaccine Doped with Manganese Adjuvant for Robust Anticancer Immunity In Vivo  ACS Publications

Adjuvant endocrine treatment strategies for non-metastatic breast cancer: a network meta-analysis...

Adjuvant endocrine treatment strategies for non-metastatic breast cancer: a network meta-analysis  The Lancet

Survival benefit added by adjuvant chemotherapy in adenoid cystic carcinoma of salivary gland - n...

Survival benefit added by adjuvant chemotherapy in adenoid cystic carcinoma of salivary gland  nature.com

Adjuvant T-DM1 in Patients With HER2-Positive Breast Cancer: Long-Term Results of the KATHERINE T...

Adjuvant T-DM1 in Patients With HER2-Positive Breast Cancer: Long-Term Results of the KATHERINE Trial  The ASCO Post

Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a rand...

Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial  The Lancet

Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the rando...

Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trial  The Lancet

FDA Approves Adjuvant Ribociclib in HR+/HER2– Breast Cancer - OncLive

FDA Approves Adjuvant Ribociclib in HR+/HER2– Breast Cancer  OncLive

Transdermal microneedles integrating biomimetic self-adjuvant particles for enhanced immunity - S...

Transdermal microneedles integrating biomimetic self-adjuvant particles for enhanced immunity  ScienceDirect.com

Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer - The New England Jou...

Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer  The New England Journal of Medicine

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma - The New England Journa...

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma  The New England Journal of Medicine

An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expand...

An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity  ScienceDirect.com

Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine - National Inst...

Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine  National Institutes of Health (NIH) | (.gov)

Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline U...

Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update  ASCO Publications

Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3...

Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial  nature.com

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma - The New England...

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma  The New England Journal of Medicine

The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally de...

The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally delivered ETEC vaccine  nature.com

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma - The New England Journal of Med...

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma  The New England Journal of Medicine

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer - The New England J...

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer  The New England Journal of Medicine

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal canc...

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer  nature.com

The scientific journey of a novel adjuvant (AS37) from bench to bedside - nature.com

The scientific journey of a novel adjuvant (AS37) from bench to bedside  nature.com

Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA v...

Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines  nature.com

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma - The New England Journal of...

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma  The New England Journal of Medicine

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF -Mutated Melanoma - The New England Journal...

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF -Mutated Melanoma  The New England Journal of Medicine

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer - The New England Jou...

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer  The New England Journal of Medicine

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma - The New England Journ...

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma  The New England Journal of Medicine

GFPBW1, a β-glucan from Grifola frondosa as vaccine adjuvant: APCs activation and maturation - na...

GFPBW1, a β-glucan from Grifola frondosa as vaccine adjuvant: APCs activation and maturation  nature.com

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma - nature.com

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma  nature.com

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy - The New England Journal...

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy  The New England Journal of Medicine

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma - The New England Journal of...

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma  The New England Journal of Medicine

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma - The New England Journ...

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma  The New England Journal of Medicine

Engineered immunogen binding to alum adjuvant enhances humoral immunity - nature.com

Engineered immunogen binding to alum adjuvant enhances humoral immunity  nature.com

Pembrolizumab Is First Adjuvant Therapy to Improve Overall Survival in Kidney Cancer - National C...

Pembrolizumab Is First Adjuvant Therapy to Improve Overall Survival in Kidney Cancer  National Cancer Institute (.gov)

Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC -...

Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC  nature.com

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer - The New Englan...

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer  The New England Journal of Medicine

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer - The New England Journal of ...

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer  The New England Journal of Medicine

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer - The New Englan...

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer  The New England Journal of Medicine

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer - The New England Jo...

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer  The New England Journal of Medicine

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma - nature.com

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma  nature.com

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer - The New England Journa...

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer  The New England Journal of Medicine

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer - The New England Journal of...

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer  The New England Journal of Medicine

Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer - The New Englan...

Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer  The New England Journal of Medicine

Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immun...

Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaques | npj Vaccines  nature.com

An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccinati...

An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination  nature.com

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years - The New England Journal of Medicine

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years  The New England Journal of Medicine

Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort stu...

Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study  nature.com

Human In vitro Modeling Identifies Adjuvant Combinations that Unlock Antigen Cross-presentation a...

Human In vitro Modeling Identifies Adjuvant Combinations that Unlock Antigen Cross-presentation and Promote T-helper 1 Development in Newborns, Adults and Elders  ScienceDirect.com

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer - The New England Journal of Medicine

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer  The New England Journal of Medicine

Adjuvant therapy options in renal cell carcinoma — targeting the metastatic cascade - nature.com

Adjuvant therapy options in renal cell carcinoma — targeting the metastatic cascade  nature.com

A combined adjuvant approach primes robust germinal center responses and humoral immunity in non-...

A combined adjuvant approach primes robust germinal center responses and humoral immunity in non-human primates  nature.com

A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of inf...

A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2  nature.com

Adjuvant chemotherapy in pathological node-negative non-small cell lung cancer | Scientific Repor...

Adjuvant chemotherapy in pathological node-negative non-small cell lung cancer | Scientific Reports  nature.com

DNA programmed Mg-Al layered double hydroxide-based bi-adjuvant nanovaccines - ScienceDirect.com

DNA programmed Mg-Al layered double hydroxide-based bi-adjuvant nanovaccines  ScienceDirect.com

Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination - nature.com

Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination  nature.com

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy - The New England Journal ...

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy  The New England Journal of Medicine

Progress in adjuvant systemic therapy for breast cancer - nature.com

Progress in adjuvant systemic therapy for breast cancer  nature.com

Neutrophil extracellular traps-inspired DNA hydrogel for wound hemostatic adjuvant - nature.com

Neutrophil extracellular traps-inspired DNA hydrogel for wound hemostatic adjuvant  nature.com

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast C...

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial  ASCO Publications

Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma - The New England Jou...

Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma  The New England Journal of Medicine

Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative bre...

Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study  nature.com

Efficacy of adjuvant trastuzumab in women with HER2-positive T1a or bN0M0 breast cancer: a popula...

Efficacy of adjuvant trastuzumab in women with HER2-positive T1a or bN0M0 breast cancer: a population-based cohort study | Scientific Reports  nature.com